Home › Mild Cognitive Impairment › Tennessee › Memphis
Mild Cognitive Impairment clinical trials in Memphis, TN
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- Neurology Clinic, P.C., Cordova · 15 mi away
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RecruitingObservational study
- Methodist University Hospital, Memphis
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Neurology Clinic, P.C., Cordova · 15 mi away
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY23 studies
- Boston, MA21 studies
- Chicago, IL17 studies
- Baltimore, MD16 studies
- Los Angeles, CA12 studies
- Miami, FL11 studies
- Philadelphia, PA11 studies
- Birmingham, AL11 studies
- San Francisco, CA10 studies
- Houston, TX10 studies
- Durham, NC9 studies
- Washington, DC9 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Sickle Cell Disease18 studies
- Lung Cancer18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.